Skip to main content
Catherine  Smith

Professor Catherine Smith

Professor of Dermatology & Therapeutics

Biography

Catherine is an Adjunct Professor of Dermatology and Therapeutics and Consultant Dermatologist at St John’s Institute of Dermatology, Kings College London and Guys and St Thomas’ Hospital.  She co-directs the Skin Therapy Research Unit and is also a lead clinician in national specialised services for adults with severe psoriasis and eczema.

Her clinical and research interests focus on inflammatory skin disease and translational medicine, extending from biomarker discovery through to interventional studies (phase II-IV), and involves major national and international collaboration. She also has a major interest in guideline development and implementation in the UK and Europe, with the aim of bringing research findings into clinical practice. She chaired the UK’s NICE guidelines on Psoriasis and the British Association of Dermatologists guidelines on Biologic therapy.

    Research

    STRU banner thumbnail (1)
    Skin Therapy Research Unit

    The Skin Therapy Research Unit (STRU) is a dermatology research and clinical trials facility based at St John’s Institute of Dermatology within Guy’s and St Thomas’ NHS Foundation Trust and King’s College, London.

    News

    Higher rate of COVID-19 death before vaccination linked to certain common inflammatory immune conditions

    People with inflammatory immune conditions that affect their skin, bowel, and joints have been linked to a greater risk of being hospitalised and death from...

    inflammatory arthritis 780x450

    Professor Catherine Smith appointed NIHR Senior Investigator

    The role is reserved for outstanding leaders of patient and people-based research.

    Catherine Smith

    Outcomes of psoriasis treatment can be predicted by white blood cell response to test, scientists discover

    The way type 2 conventional dendritic cells (cDC2) respond to an in vitro test before the patient commences therapy can predict whether the therapy is going...

    Severe Psoriasis

    COVID-19 vaccine: Antibody response weakened in patients receiving methotrexate

    The antibody – but not the T cell – response to the first dose of the Pfizer COVID-19 vaccine is weakened in patients taking the immunosuppressant...

    covid vaccine

      Research

      STRU banner thumbnail (1)
      Skin Therapy Research Unit

      The Skin Therapy Research Unit (STRU) is a dermatology research and clinical trials facility based at St John’s Institute of Dermatology within Guy’s and St Thomas’ NHS Foundation Trust and King’s College, London.

      News

      Higher rate of COVID-19 death before vaccination linked to certain common inflammatory immune conditions

      People with inflammatory immune conditions that affect their skin, bowel, and joints have been linked to a greater risk of being hospitalised and death from...

      inflammatory arthritis 780x450

      Professor Catherine Smith appointed NIHR Senior Investigator

      The role is reserved for outstanding leaders of patient and people-based research.

      Catherine Smith

      Outcomes of psoriasis treatment can be predicted by white blood cell response to test, scientists discover

      The way type 2 conventional dendritic cells (cDC2) respond to an in vitro test before the patient commences therapy can predict whether the therapy is going...

      Severe Psoriasis

      COVID-19 vaccine: Antibody response weakened in patients receiving methotrexate

      The antibody – but not the T cell – response to the first dose of the Pfizer COVID-19 vaccine is weakened in patients taking the immunosuppressant...

      covid vaccine